ACCD - Accolade - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart

Accolade's activity chart (see below) currently has 250 price targets and 179 ratings on display.

Stock Analyst Price Targets - Review

Analysts' price targets on this stock were met 53.98% of the time, taking 71.2 days on average.

Most recent stock forecast was given by JEFF GARRO from STEPHENS on 12-Feb-2025. First documented stock forecast 27-Jul-2020.

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Hold Since 12-Feb-2025

$7.03

$8

1 years 9 months 7 days ago
(12-Feb-2025)

1/14 (7.14%)

$0.13 (1.88%)

51

Buy Since 17-Nov-2020

$7.03

1 years 10 months 10 days ago
(09-Jan-2025)

6/12 (50%)

$0.17 (2.48%)

94

Buy Since 03-Jul-2023

$5.75

1 years 10 months 11 days ago
(08-Jan-2025)

3/11 (27.27%)

$1.71 (42.33%)

51

Buy Since 07-Jul-2021

$7.5

$7.5

1 years 10 months 11 days ago
(08-Jan-2025)

6/21 (28.57%)

$0.64 (9.33%)

75

Buy Since 02-Feb-2023

$16

1 years 10 months 11 days ago
(08-Jan-2025)

2/3 (66.67%)

$1.01 (6.74%)

79

Show more analysts

Please expand the browser size to see the chart

What is ACCD (Accolade) average time for price targets to be met?

On average it took 71 days for the stock forecasts to be reached, with an average price target met ratio of 53.98%.

Which analyst most recently updated their price target on ACCD (Accolade)?

Jeffrey Garro

Which analyst has the most public recommendations on ACCD (Accolade)?

Jeffrey Garro works at STEPHENS and has 6 price targets and 3 ratings on ACCD

Which analyst is the currently most bullish on ACCD (Accolade)?

Robert Jones with the highest potential upside of $51.98

Which analyst is the currently most reserved on ACCD (Accolade)?

Ricky Goldwasser with the lowest potential downside of -$2.02
✖

To continue looking at which analysts cover the stock please register to the basic or advanced membership

To continue looking at analysts data please register to the advanced membership

What is AnaChart?